APA

Paspatis G. A., Sfyridaki A., Papanikolaou N., Triantafyllou K., Livadiotaki A., Kapsoritakis A. & Lydataki N. (20030610). Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer. : Pathophysiology of haemostasis and thrombosis.

Chicago

Paspatis Gregorios A, Sfyridaki Aikaterini, Papanikolaou Nikolaos, Triantafyllou Kostantinos, Livadiotaki Aikaterini, Kapsoritakis Andreas and Lydataki Niki. 20030610. Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer. : Pathophysiology of haemostasis and thrombosis.

Harvard

Paspatis G. A., Sfyridaki A., Papanikolaou N., Triantafyllou K., Livadiotaki A., Kapsoritakis A. and Lydataki N. (20030610). Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer. : Pathophysiology of haemostasis and thrombosis.

MLA

Paspatis Gregorios A, Sfyridaki Aikaterini, Papanikolaou Nikolaos, Triantafyllou Kostantinos, Livadiotaki Aikaterini, Kapsoritakis Andreas and Lydataki Niki. Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer. : Pathophysiology of haemostasis and thrombosis. 20030610.